The market share liability (MSL) theory generated much concern among marketers when it was introduced in the Sindell case in California in 1980. In the twelve years since that decision, courts in several states have considered the applicability of MSL in a variety of situations and have refined the theory considerably. This paper surveys key cases since 1980 and concludes that MSL has been upheld only by a handful of states and only in cases involving diethylstilbestrol (DES). The issues raised in Sindell and the ways in which courts have dealt with these issues are examined, and a policy solution for the recurring problems is proposed.
Get full access to this article
View all access options for this article.
References
1.
American Law of Products Liability (1987), “Market-Share Liability Theory and Its Variants,”9, 28–59.
Baydstun, and Webber (1988), “The Narrow Scope of Market Share Liability,”For the Defense, (April 23).
4.
Besser v. E.R. Squibb & Sons (1989), 539 N.Y.S.2d 734 (A.D. 1 Dept.).
5.
Bichler V. Eli Lilly & Co. (1982), N.Y. 436 N.E. 2d 182.
6.
BoedeckerKarl A., and MorganFred W. (1986), “Intra-Industry Joint Liability: Implications for Marketing,”Journal of Public Policy & Marketing, 5, 72–81.
7.
Brown v. Superior Court (1988), 245 Cal. Rptr. 412 (Cal.)
8.
Collins v. Eli Lilly & Co. (1984), 116 Wis.2d 166; 342 N.W.2d 37; cert. denied 469 U.S. 826.
9.
FernFrederick H., and McHughLeslie Steineker (1990), “Market Share Liability for Pharmaceuticals: The Distinction Between DES and DPT,”Journal of Legal Medicine, (11), 391–426.
10.
Howe v. Pioneer Manufacturing Co. (1968), 68 Cal. Rptr. 617.
11.
Hymowitz v. Eli Lilly & Co. (1989), 73 N.Y.2d 487, 541 N.Y.S. 2d 941 (Ct.App.), cert denied 110 S.Ct. 350.
12.
KingGeorge H. (1989), “A Prescription for Applying Strict Liability: Not All Drugs Deserve Comment k Immunization, Brown v. Superior Court, 44 Cal.3d 1049, 751 P.2d 470, 245 Cal. Rptr. 412 (1988), Arizona State Law Journal, 21, 809–831.
13.
Jolly v. Eli Lilly & Co. (1988), 245 Cal. Rptr. 658 (Cal.).
14.
MarcusAmy Dockser (1991), “Limits on Personal-Injury Suits Urged,”The Wall Street Journal, (April 23), B1.
15.
Martin v. Abbott Laboratories (1984), 102 Wash.2d 581, 689 P.2d 368 (Wash.).
16.
Mulcahy v. Eli Lilly & Co. (1986), 386 N.W.2d 67.
17.
Mullen v. Armstrong World Industries, Inc. (1988), 200 Cal.App.3d 250, 246 Cal. Rptr. 32 (Cal.App. 1 Dist.).
18.
NaceAndrew B. (1991), “Market Share Liability: A Current Assessment of a Decade-Old Doctrine,”Vanderbilt Law Review, 44, 395–439.
19.
National Childhood Vaccine Injury Act (1986), 42 U.S.C.A. Sec 300aa-1 et seq.
20.
O'Toole, Leslie Calkins (1986), “Wilder v. Amatex Corp.: A First Step Toward Ameliorating the Effect of Statutes of Repose on Plaintiffs With Delayed Manifestation Diseases,”North Carolina Law Review, 64, 416–441.
21.
PageJoseph A. (1973), “Generic Product Risks: The Case Against Comment k and for Strict Tort Liability,”New York University Law Review, 58(October), 853–891.
22.
Salt Lake Tribune (1991), “Vaccine Injury Program Studies a Claim's Merit,” (July 9), A9.
23.
ScammonDebra L., and SheffetMary Jane (1986), “Legal Issues in Channels Modification Decisions: The Question of Refusals to Deal,”Journal of Public Policy & Marketing, 5, 82–96.
24.
SheffetMary Jane (1983), “Market Share Liability: A New Doctrine of Causation in Product Liability,”Journal of Marketing, 47(Winter), 35–43.
25.
Sheffield v. Eli Lilly & Co. (1983), 144 Cal.App.3d 583, 192 Cal. Rptr. 870 (App.).
26.
ShermanRorie (1990), “New DES Front,”National Law Journal, 12(March 12), 1, 26–27.
27.
Sindell v. Abbott Laboratories et al. (1980), 26 Cal.3d 588.
28.
Staff (1989), “Go-Ahead Given for Hundreds of DES Suits,”National Law Journal, 11(April 17), 6.
WilnerDiane S., and GayerLee S. (1989), “Hymowitz v. Eli Lilly: New York Adopts a ‘National Risk’ Doctrine for DES,”Tort and Insurance Law Journal, 25(Fall), 150–156.
34.
WilsonWilliam D. (1990), “Market Share Liability—Did New York Go Too Far?: Hymowitz v. Eli Lilly & Co.,”St. John's Law Review, 64, 363–377.
35.
Zafft v. Eli Lilly & Co. (1986), 676 S.W.2d 241 (Mo.).
